To assess how early and comprehensive genomic testing influences clinical management and outcomes in individuals diagnosed with neonatal diabetes.
International cohort study analyzing patients presenting with neonatal diabetes who received early, comprehensive genomic sequencing.
Early genomic testing provides rapid molecular diagnoses that guide targeted treatment strategies and inform ongoing clinical care in neonatal diabetes.